Immunovant Stock Price on June 9, 2025
| IMVT Stock | USD 18.39 0.45 2.51% |
If you're considering investing in Immunovant Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immunovant stands at 18.39, as last reported on the 24th of July, with the highest price reaching 18.39 and the lowest price hitting 17.94 during the day. Immunovant appears to be not too volatile, given 3 months investment horizon. Immunovant holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Immunovant, which you can use to evaluate the volatility of the firm. Please utilize Immunovant's Downside Deviation of 2.88, risk adjusted performance of 0.1075, and Market Risk Adjusted Performance of 0.2354 to validate if our risk estimates are consistent with your expectations.
Other Stockholder Equity is likely to gain to about 2 B in 2025, whereas Total Stockholder Equity is likely to drop slightly above 363.2 M in 2025. . Price Earnings Ratio is likely to drop to -6.57 in 2025. Price Book Value Ratio is likely to drop to 3.48 in 2025. Immunovant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immunovant | Build AI portfolio with Immunovant Stock |
Related Headline
Akero Therapeutics Headline on 9th of June 2025
Rumor Fuels Akero Therapeutics Stock Movement AKRO Stock New... by gurufocus.com
Speculation of a potential acquisition involving Akero Therapeutics has surfaced, as mentioned in a blog focused on mergers and acquisitions. This rumor
Immunovant Valuation on June 9, 2025
It is possible to determine the worth of Immunovant on a given historical date. On June 9, 2025 Immunovant was worth 17.08 at the beginning of the trading date compared to the closed value of 16.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunovant stock. Still, in general, we apply an absolute valuation method to find Immunovant's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunovant where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunovant's related companies.
| Open | High | Low | Close | Volume | |
| 16.35 | 17.10 | 16.26 | 16.77 | 2,179,239 | |
06/09/2025 | 17.08 | 17.15 | 15.95 | 16.29 | 1,057,905 |
| 16.38 | 16.95 | 16.30 | 16.74 | 1,540,553 |
| Backtest Immunovant | | | Immunovant History | | | Immunovant Valuation | Previous | Next |
Immunovant Trading Date Momentum on June 9, 2025
| On June 10 2025 Immunovant was traded for 16.74 at the closing time. The top price for the day was 16.95 and the lowest listed price was 16.30 . The trading volume for the day was 1.5 M. The trading history from June 10, 2025 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 2.76% . The trading delta at closing time against the current closing price is 1.53% . |
Immunovant Fundamentals Correlations and Trends
By evaluating Immunovant's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunovant's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunovant financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunovant Stock history
Immunovant investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunovant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunovant will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunovant stock prices may prove useful in developing a viable investing in Immunovant
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 151.6 M | 93.2 M | |
| Net Loss | (405.00) | (425.25) |
Immunovant Quarterly Net Working Capital |
|
Immunovant Stock Technical Analysis
Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunovant Period Price Range
Low | July 24, 2025
| High |
0.00 | 0.00 |
Immunovant cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immunovant July 24, 2025 Market Strength
Market strength indicators help investors to evaluate how Immunovant stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunovant shares will generate the highest return on investment. By undertsting and applying Immunovant stock market strength indicators, traders can identify Immunovant entry and exit signals to maximize returns
Immunovant Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunovant's price direction in advance. Along with the technical and fundamental analysis of Immunovant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunovant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1075 | |||
| Jensen Alpha | 0.0286 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0427 | |||
| Treynor Ratio | 0.2254 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.